Huang, Jiayi http://orcid.org/0000-0002-5153-506X
Chaudhary, Rekha
Cohen, Adam L.
Fink, Karen
Goldlust, Samuel
Boockvar, John
Chinnaiyan, Prakash
Wan, Leping
Marcus, Stephen
Campian, Jian L.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
https://doi.org/10.1007/s11060-019-03125-y
Funding for this research was provided by:
Cantex Pharmaceuticals (NA)
Article History
Received: 15 January 2019
Accepted: 8 February 2019
First Online: 15 February 2019
Compliance with ethical standards
:
: JH reports research support from Cantex Pharmaceuticals for the submitted work as well as research support from Pfizer for topics outside this work. SG reports consultant fees and Speaker’s honoraria from Wex Pharma and Novocure, outside of the submitted work.